Understanding how patients access medicines in England

This content relates to the following topics:

Medicines are a vital part of modern health care. The question of how to provide patients with access to innovative medicines, in a way that the NHS can afford, has been discussed by policy-makers, politicians and industry for many years. In 2018, The King’s Fund released a policy report discussing some of the key issues, but the situation is evolving and the National Institute for Health and Care Excellence (NICE) is currently reviewing how it appraises new medicines.  

This free online event will explore the current medicines landscape and highlight some of the key challenges to patients accessing medicines in England. The discussion will include patient, industry and system perspectives on the medicines access process and the audience will be invited to send in their own questions to the panel beforehand.  

Register your free place here

Event partner

This event is being held in partnership with AbbVie. 

If you're interested in partnering with us on an online event please email Chloe Smithers or call her on 020 7307 2482.




Sally Warren

Director of Policy, The King’s Fund


Paul Catchpole

Value and Access Director, The Association of the British Pharmaceutical Industry (ABPI)


Bradley Price

Policy and Public Affairs Manager, Sarcoma UK


Dominic Pivonka

Head of Health Technology Assessments and Pricing, AbbVie


Nina Pinwill

Head of Commercial Operations and Acting Commercial Medicines Director (due to COVID-19), NHS England and NHS Improvement


Register here to watch this event on 18 June or later on demand.